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Lupus miliaris disseminatus faciei (LMDF) is an
uncommon granulomatous disease of unknown
origin. It most commonly presents as yellow-brown
to red papules on the central face and often involves
the lower eyelids. Extrafacial manifestations have
been reported but almost always coexist with facial
involvement. Histopathology findings show epithe-
lioid cell granulomas with variable caseous necrosis
depending on the timing of the biopsy. We present a
case of LMDF occurring solely on the posterior neck
without facial involvement.
CASE REPORT
A 65-year-old white womanwith amedical history
of cutaneous squamous cell carcinoma of the arm
and epidermal inclusion cysts presented with
numerous small papules on the posterior neck that
were present for several months before consultation.
She denied any associated symptoms including pru-
ritus, pain, or burning. She denied a history of
flushing, recurrent lesions on her neck, lung disease,
and infection with tuberculosis. Examination found a
group of approximately twelve 2- to 3-mm dome-
shaped yellow-brown papules on the posterior neck
(Fig 1). Similar lesions were not observed elsewhere
on the body. The differential diagnosis included
milia, herpes simplex virus infection, and elastosis
perforans serpiginosa. A 4-mm punch biopsy found
a well-formed granuloma with central caseous ne-
crosis accompanied by a perivascular lymphocytic
infiltrate (Figs 2 and 3). The overlying epidermis was
unaffected. Periodic acid-Schiff and Fite’s acid-fastEast Carolina University Dermatologya; Dermatology Associ-
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nois.stains were negative for microorganisms. The patient
declined treatment, and at follow-up 1 month later,
the lesions were unchanged.
DISCUSSION
LMDF, also known as acne agminata, was first
described in 1878,1 and approximately 200 cases
have since been reported in the literature.2 It most
commonly manifests as solitary or multiple, discrete,
1- to 3-mm skin-colored to yellow-brown to red
papules involving the central and lateral aspects of
the face and lower eyelids with occasional extension
to the chin and neck. Diascopy of the lesions often
finds an apple-jelly color.3 Extrafacial lesions are not
infrequent but almost always coexist with facial
involvement.4 There are 2 previous reports of
isolated axillary LMDF4,5 and 1 report of LMDF
involving the neck and chest without facial involve-
ment.2 Solitary lesions on the antihelix and lower
back have also been reported.6
The hallmark histopathologic feature of LMDF is
an epithelioid cell granulomawith caseous necrosis.3
However, the changes vary according to the age of
the lesions at the time of biopsy. Early lesions
typically lack granuloma formation, and only a
nonspecific perivascular and periappendageal infil-
trate of lymphocytes, histiocytes, and scattered
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Fig 1. Lupus miliaris disseminatus faciei. Approximately
twelve 2- to 3-mm dome-shaped skin-colored papules on
the posterior neck. Telangiectasia is absent.
Fig 2. Histopathology of lupus miliaris disseminatus
faciei. A well-formed granuloma with central caseous
necrosis accompanied by a perivascular lymphocytic
infiltrate. (Hematoxylin-eosin stain.)
Fig 3. Histopathology of lupus miliaris disseminatus
faciei. Caseous necrosis characteristic of well-developed




320 Pruitt et aldeveloped, perifollicular epithelioid cell granulomas
form. Three histologic stages have been described:
epithelioid cell granuloma without caseous necrosis,
epithelioid cell granuloma with neutrophilic abscess
formation, and epithelioid cell granuloma with
caseous necrosis. Perifollicular fibrosis with scat-
tered lymphocytes and histiocytes are seen in late
lesions.7,8
The etiology and pathogenesis of LMDF remains
unclear. Originally, it was thought to be a reaction
pattern to Mycobacterium tuberculosis; however,
there is no evidence to date supporting this idea.9
More recently, LMDF has been viewed as a type of
granulomatous rosacea, as the granulomas in LMDF
occur in association with pilosebaceous units, and
epithelioid cell granulomas have been identified in
some cases of rosacea.10 However, LMDF occurs in
different anatomic locations than rosacea; has no
associated erythema, flushing, or telangiectasias;
and has a self-limited course unlike rosacea.
These significant differences make it difficult to
accept this concept, and our case of exclusive
posterior neck involvement supports the distinctionof LMDF from rosacea. LMDF has also been
postulated to occur as a reaction to Demodex
folliculorum, ruptured hair follicles, and ruptured
epidermal inclusion cysts, but these associations
have not been confirmed. LMDF has also been
described as a micropapular form of sarcoidosis,
but this diagnosis is easily ruled out with the
history, physical examination, laboratory investiga-
tions, and chest radiograph.11
LMDF typically has a chronic but benign course
with spontaneous involution in 12 to 24 months
leaving behind small, pitted scars. Various treatments
are reported in the literature, but specific treatment
guidelines are lacking. Retinoid, anti-inflammatory,
immunosuppressive, and antimicrobial medications
as well as laser therapy have been used for the
treatment of LMDF, but no single agent is consistently
effective.8,12,13 Tetracyclines are commonly used as a
first-line treatment, but their efficacy in this disorder
is often unsatisfactory. Treatment with oral prednis-
olone has been found to prevent scarring when
initiated early in the disease course.12 Given the
rarity of LMDF and its tendency to spontaneously
resolve, the effect of different therapies on the
disorder is difficult to evaluate.
LMDF represents a diagnostic challenge given its
highly diverse clinical presentations. Our patient’s
case represents an unusual clinical presentation of
LMDF involving a localized area of the posterior
neck without facial involvement and highlights the
importance of characteristic histopathologic findings
in establishing the diagnosis. This case also further
supports LMDF as a distinct clinical entity from
rosacea. We report this unusual case to remind
clinicians that LMDF can occur in nonfacial areas
without concurrent facial involvement.
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